Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 10 Feb 23 424B4 Prospectus supplement with pricing info
- 10 Feb 23 EFFECT Notice of effectiveness
-
2 Feb 23 S-1/A IPO registration (amended)
- 18 Jan 23 S-1 IPO registration
MLYS similar filings
Filing view
External links
Exhibit 107
Calculation of Filing Fee Table
Form S-1
Mineralys Therapeutics, Inc.
Table 1 - Newly Registered Securities
Security Type | Security Class Title | Fee Calculation Rule | Amount Registered(1) | Proposed Maximum Offering Price Per Share | Maximum Aggregate Offering Price(2) | Fee Rate | Amount of Registration Fee | ||||||||||||||||
Equity | Common Stock, par value $0.0001 per share | Rule 457(a) | 11,500,000 | 16.00 | $184,000,000 | 0.00011020 | $20,277 | ||||||||||||||||
Total Offering Amounts | — | $184,000,000 | 0.00011020 | $20,277 | |||||||||||||||||||
Total Fees Previously Paid | — | — | — | $11,020 | |||||||||||||||||||
Total Fees Offsets | — | — | — | — | |||||||||||||||||||
Net Fee Due | — | — | — | $9,257 |
(1) Includes 1,500,000 shares of common stock that the underwriters have the option to purchase.
(2) Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(a) under the Securities Act of 1933, as amended.